Double blind randomized clinical trial controlled by placebo with a FOS enriched cookie on saciety and cardiovascular risk factors in obese patients

被引:11
|
作者
de Luis, D. A. [1 ,2 ]
de la Fuente, B. [1 ,2 ]
Izaola, O. [1 ,2 ]
Aller, R. [1 ,2 ]
Gutierrez, S. [3 ]
Morillo, Maria [4 ]
机构
[1] Univ Valladolid, Fac Med, Inst Endocrinol & Nutr, Simancas 47130, Valladolid, Spain
[2] Univ Valladolid, Hosp Rio Hortega, Unidad Apoyo Invest, Simancas 47130, Valladolid, Spain
[3] CARTIF, Div Invest Gullon SA, Valladolid, Spain
[4] CARTIF, Div Aliment, Valladolid, Spain
关键词
Cardiovascular risk factors; Cookies; FOS; Satiety; Obesity; OLIGOFRUCTOSE PROMOTES SATIETY; MEAL INTAKE; HIGH-FAT; APPETITE; ENERGY; FOOD; SNACK; DIET; AIR;
D O I
10.3305/nh.2013.28.1.6255
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: It is essential to determine which snack foods are most affective for appetite control. The objective of the current study was to assess the responses of two different cookies on satiety and cardiovascular risk factors. Material and Methods: 38 patients were randomized: group I (FOS enriched cookie, n=19) and group II (control cookie, n=19). Previous and after 1 month, the subjects rated their feelings of satiety/hunger with a test meal of 5 cookies. Results: After the test meal, the basal area under curve of the first hunger/satiety score was higher with satiety cookie than with control cookie, the data after 1 month of treatment was higher with satiety cookie than with control cookie, too. The score was higher than the fasting level for 20 minutes with satiety cookie and for 40 minutes with the same cookie, too. In satiety group, these scores (20 min and 40 min) were higher than control group before and after 1 month of treatment. The results were in the same way with the 100 mm 5-point visual satiety scale. Cardiovascular risk factors and dietary intake remained unchanged after dietary intervention. Conclusion: A FOS enriched cookie produced greater ratings of satiety than a control cookie, without effects on cardiovascular risk factors or dietary intakes. (Nutr Hosp. 2013;28:78-85) DOI:10.3305/nh.2013.28.1.6255
引用
收藏
页码:78 / 85
页数:8
相关论文
共 50 条
  • [21] Contributions of vitamin D in the management of depressive symptoms and cardiovascular risk factors: study protocol for a randomized, double-blind, placebo-controlled clinical trial
    Catarina Magalhães Porto
    Tatiana de Paula Santana da Silva
    Everton Botelho Sougey
    Trials, 20
  • [22] Effects of vitamin D supplementation on cardiovascular risk factors in shift workers Study protocol for randomized, double-blind, placebo-controlled clinical trial
    Fajardo, Virginia Capistrano
    Pereira de Oliveira, Fernando Luiz
    Lins Machado-Coelho, George Luiz
    Pedrosa Pimenta, Fausto Aloisio
    de Freitas, Silvia Nascimento
    Pinho Ribeiro, Antonio Luiz
    Sarquis Soares, Maria Marta
    Lauria, Marcio Weissheimer
    Farias, Rosielle da Costa
    Franca, Ive Bahia
    do Nascimento Neto, Raimundo Marques
    MEDICINE, 2019, 98 (18)
  • [23] Cardiovascular and osteoporosis protection at menopause with lycopene: A placebo-controlled double-blind randomized clinical trial
    Meeta, Meeta
    Sharma, Sudhaa
    Unni, Jyothi
    Khandelwal, Sunila
    Choranur, Ambuja
    Malik, Sonia
    JOURNAL OF MID-LIFE HEALTH, 2022, 13 (01) : 50 - 56
  • [24] Effect of Alpha-Lipoic Acid Supplementation on Endothelial Function and Cardiovascular Risk Factors in Overweight/Obese Youths: A Double-Blind, Placebo-Controlled Randomized Trial
    Tromba, Luciana
    Perla, Francesco Massimo
    Carbotta, Giovanni
    Chiesa, Claudio
    Pacifico, Lucia
    NUTRIENTS, 2019, 11 (02)
  • [25] Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial
    Hsu, Chung-Hua
    Tsai, Tung-Hu
    Kao, Yung-Hsi
    Hwang, Kung-Chang
    Tseng, Ting-Yu
    Chou, Pesus
    CLINICAL NUTRITION, 2008, 27 (03) : 363 - 370
  • [26] RANDOMIZED, PLACEBO, CONTROLLED, DOUBLE-BLIND TRIAL OF MELATONIN IN CHOLANGIOCARCINOMA PATIENTS
    Manprasert, W.
    Johns, N. P.
    Sookprasert, A.
    Kantpittaya, J.
    Johns, J.
    Konsil, J.
    Weerapreeyakul, T.
    Phongthai, P.
    Porasutpathana, S.
    Laolukana, W.
    VALUE IN HEALTH, 2010, 13 (07) : A510 - A510
  • [27] Effect of nano-curcumin supplementation on angina status, and traditional and novel cardiovascular risk factors in overweight or obese patients with coronary slow flow phenomenon: a randomized double-blind placebo-controlled clinical trial
    Rezaei, Mahsa
    Soltani, Mitra
    Alipoor, Elham
    Rezayat, Seyed Mahdi
    Vasheghani-Farahani, Ali
    Yaseri, Mehdi
    Firouzi, Ata
    Hosseinzadeh-Attar, Mohammad Javad
    BMC NUTRITION, 2024, 10 (01)
  • [28] Effects of sea buckthorn puree on risk factors of cardiovascular disease in hypercholesterolemia population: a double-blind, randomized, placebo-controlled trial
    Zhou, Fangfei
    Zhang, Jian
    Zhao, Ai
    Zhang, Yumei
    Wang, Peiyu
    ANIMAL BIOTECHNOLOGY, 2022, 33 (05) : 955 - 963
  • [29] Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus
    Carneiro, JRM
    Sato, EI
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (06) : 1275 - 1279
  • [30] PLACEBO CONTROLLED DOUBLE-BLIND TRIAL OF FLUVOXAMINE MALEATE IN THE OBESE
    ABELL, CA
    FARQUHAR, DL
    GALLOWAY, SM
    STEVEN, F
    PHILIP, AE
    MUNRO, JF
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 1986, 30 (02) : 143 - 146